Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jaclp.2024.07.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pimavanserin for Delirium Management in the Setting of Parkinson's Disease: A Case Report.
J Acad Consult Liaison Psychiatry
July 2024
Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Stanford, CA.
Pimavanserin in Dementia-Related Psychosis.
N Engl J Med
July 2021
From the Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, and Delirium Services, Mount Sinai System of Hospitals, New York.
Hallucinations, Delusions and Impulse Control Disorders in Parkinson Disease.
Clin Geriatr Med
February 2020
The Edmond J. Safra Program in Parkinson Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Division of Neurology, Department of Medicine, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada; Krembil Research Institute, Toronto, Ontario, Canada.
Psychotic and compulsive symptoms in Parkinson disease are highly prevalent and associated with poor outcomes and greater caregiver burden. When acute, delirium should be ruled out or treated accordingly. When chronic, comorbid systemic illnesses, dementia, and psychiatric disorders should be considered.
View Article and Find Full Text PDFAdvances in Management of Psychosis in Neurodegenerative Diseases.
Curr Treat Options Neurol
January 2019
Department of Psychiatry, Yale School of Medicine, 300 George St., Suite 901, New Haven, CT, 06511, USA.
Purpose Of The Review: Psychosis is broadly defined as a disengagement from reality. It describes syndromes that impair both thought content and thought process. Psychosis negatively impacts an individual's quality of life, in addition to the families caring for them.
View Article and Find Full Text PDFTreatment of Parkinson's disease psychosis.
Med Int Rev
December 2017
Departments of Psychiatry, Neurology, Radiology and Neuroscience, Washington University in St. Louis.
Early in the course of Parkinson disease (PD), treatment usually goes well. However, after five to ten years, things start to change as treatment requires higher doses of medications and side effects become more problematic. One of the most difficult problems is the development of hallucinations or delusions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!